These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 556116)
21. [New aspects of therapy with oral antidiabetic agents]. Haslbeck M Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940 [No Abstract] [Full Text] [Related]
22. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells. Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective. Manolopoulos VG; Ragia G; Tavridou A Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065 [TBL] [Abstract][Full Text] [Related]
24. Use of noninsulin antidiabetic medications in hospitalized patients. Kopecky C Crit Care Nurs Clin North Am; 2013 Mar; 25(1):39-53. PubMed ID: 23410645 [TBL] [Abstract][Full Text] [Related]
25. [Mode of action of oral antidiabetic drugs]. Frey H Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814 [No Abstract] [Full Text] [Related]
27. [Diabetes mellitus and obesity: monotherapy using biguanides]. Bäbler M Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806 [No Abstract] [Full Text] [Related]
28. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus]. GUTSCHE H Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204 [No Abstract] [Full Text] [Related]
32. [Oral therapy of diabetes. Suggestions and requirements for use]. Hasselblatt A ZFA (Stuttgart); 1982 Sep; 58(26):1384-9. PubMed ID: 7180121 [No Abstract] [Full Text] [Related]
33. [Long term efficacy and tolerance of antidiabetic treatments. New data]. Mirouze J Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493 [No Abstract] [Full Text] [Related]
34. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
35. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics]. Losert W; Hoder A; Scholz C Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311 [No Abstract] [Full Text] [Related]
37. [Indication and method of administration of oral antidiabetic agents]. Tasaka Y Nihon Rinsho; 1997 Nov; 55 Suppl():99-103. PubMed ID: 9434451 [No Abstract] [Full Text] [Related]
38. [Recent development in the diabetes-therapy]. Landgraf R; Dieterle C Internist (Berl); 1977 Oct; 18(10):509-19. PubMed ID: 412809 [No Abstract] [Full Text] [Related]
39. [Comparative study of the effect of a principle extracted from Eugenia Jambolana bark with NN-methyldimethyl biguanide and glybutamide on induced hypoglycemia in normal rats]. Ratsimamanga AR; Lefournier-Contensou C; Bibal-Prot P C R Acad Hebd Seances Acad Sci D; 1972 Aug; 275(8):913-5. PubMed ID: 4628567 [No Abstract] [Full Text] [Related]
40. When--and how--to use an oral agent. Shuman CR Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]